219 related articles for article (PubMed ID: 24648519)
1. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model.
Wang Y; Li G; Mao F; Li X; Liu Q; Chen L; Lv L; Wang X; Wu J; Dai W; Wang G; Zhao E; Tang KF; Sun ZS
J Biol Chem; 2014 May; 289(20):14225-38. PubMed ID: 24648519
[TBL] [Abstract][Full Text] [Related]
2. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
Mei FC; Young TW; Liu J; Cheng X
FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
[TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.
Young T; Mei F; Liu J; Bast RC; Kurosky A; Cheng X
Oncogene; 2005 Sep; 24(40):6174-84. PubMed ID: 15940260
[TBL] [Abstract][Full Text] [Related]
4. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma.
Mo Y; Midorikawa K; Zhang Z; Zhou X; Ma N; Huang G; Hiraku Y; Oikawa S; Murata M
Cancer Lett; 2012 Oct; 323(2):147-54. PubMed ID: 22487779
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer.
Jin Z; Feng X; Jian Q; Cheng Y; Gao Y; Zhang X; Wang L; Zhang Y; Huang W; Fan X; Chen S; Yu H; Zhao Z; Dong M; Liu J; Mori Y; Meltzer SJ
Anticancer Res; 2013 Nov; 33(11):5199-203. PubMed ID: 24222170
[TBL] [Abstract][Full Text] [Related]
8. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
[TBL] [Abstract][Full Text] [Related]
9. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation.
Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK
Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
[TBL] [Abstract][Full Text] [Related]
11. Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry.
Young TW; Mei FC; Yang G; Thompson-Lanza JA; Liu J; Cheng X
Cancer Res; 2004 Jul; 64(13):4577-84. PubMed ID: 15231669
[TBL] [Abstract][Full Text] [Related]
12. Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.
Sato M; Larsen JE; Lee W; Sun H; Shames DS; Dalvi MP; Ramirez RD; Tang H; DiMaio JM; Gao B; Xie Y; Wistuba II; Gazdar AF; Shay JW; Minna JD
Mol Cancer Res; 2013 Jun; 11(6):638-50. PubMed ID: 23449933
[TBL] [Abstract][Full Text] [Related]
13. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.
Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
15. Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer.
Wang G; Li X; Tian W; Wang Y; Wu D; Sun Z; Zhao E
Genes Chromosomes Cancer; 2015 Jul; 54(7):453-62. PubMed ID: 25931269
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
Sung HY; Park AK; Ju W; Ahn JH
Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha inhibits senescence-like phenotype and facilitates transformation induced by oncogenic ras in human mammary epithelial cells.
Liu Z; Wang L; Yang J; Bandyopadhyay A; Kaklamani V; Wang S; Sun LZ
Oncotarget; 2016 Jun; 7(26):39097-39107. PubMed ID: 27259243
[TBL] [Abstract][Full Text] [Related]
19. Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma.
Jazaeri AA; Bryant JL; Park H; Li H; Dahiya N; Stoler MH; Ferriss JS; Dutta A
Neoplasia; 2011 Oct; 13(10):899-911. PubMed ID: 22028616
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]